Find Clinical Trial

Home » Find Clinical Trials » Effects of ivabradine IV versus placebo on haemodynamic parameters in patients with a low cardiac output syndrome following planned coronary artery bypass surgery and requiring positive inotropic treatment. A phase II, single blind, exploratory, multicentre study.

Effects of ivabradine IV versus placebo on haemodynamic parameters in patients with a low cardiac output syndrome following planned coronary artery bypass surgery and requiring positive inotropic treatment. A phase II, single blind, exploratory, multicentre study.

← Back

Study Phase	Phase 2

Therapeutic Area	Cardiovascular Diseases

Indication	Coronary Artery Disease

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	IVABRADINE, S016257

Active Substance Code	S016257

Protocol Code	CL2-16257-088

EudraCT Code	2009-018175-14

Documents and links

Results summary	READ MORE

Scientific publication	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.